Remarkably, three IFN-related pathways were enriched in anti-MDA5+ DM patients (Figure 4C), and these three signaling pathways were significantly activated in anti-MDA5+ patients (Figure 4D). This evidence concerns the gene IFNA1 and dermatomyositis.